Volume 61, Issue 3, Pages (September 2014)

Slides:



Advertisements
Similar presentations
“NHSBT strategic vision meeting” Dr. Les Russell - October Tel +44 (0) Confidential to OrganOx.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Improving Outcomes in DCD Renal Transplantation Reference: Hoogland ERP, Snoeijs MGJ, van Heurn LWE. DCD kidney transplantation: Results and measures to.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 56, Issue 4, Pages (April 2012)
Preservation of Renal Function: The Key to Long-term Kidney Allograft and Patient Survival.
Corrigendum to “MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation” [J Hepatol.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
From: Rewarming Machine Perfusion System for Liver Transplantation
Liver transplantation using Donation after Cardiac Death donors
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice  Parambir.
Stuart J. Forbes, Sanjeev Gupta, Anil Dhawan  Journal of Hepatology 
Machine perfusion in liver transplantation as a tool to prevent non-anastomotic biliary strictures: Rationale, current evidence and future directions 
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Impact of static cold storage VS hypothermic machine preservation on ischemic kidney graft: inflammatory cytokines and adhesion molecules as markers of.
Ype P. de Jong, Charles M. Rice, Alexander Ploss  Journal of Hepatology 
Allogeneic hematopoietic cell transplant in HCV-infected patients
Living donor liver transplantation: is the hype over?
What lessons have we learned in pediatric liver transplantation?
Reply to: “DCD consensus and futility in liver transplantation”
Volume 63, Issue 1, Pages (July 2015)
The place of downstaging for hepatocellular carcinoma
S. Sagedal, A. Hartmann, H. Rollag  Clinical Microbiology and Infection 
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Hepatitis C core protein – The “core” of immune deception?
Jay A. Graham, James V. Guarrera  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 54, Issue 5, Pages (May 2011)
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
Who should get a liver graft?
EASL Clinical Practice Guidelines: Wilson’s disease
Pierre Nahon, Jessica Zucman-Rossi  Journal of Hepatology 
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 67, Issue 6, Pages (December 2017)
Volume 57, Issue 5, Pages (November 2012)
Hepatology may have problems with putative surrogate outcome measures
V. De Santis, M. Singer  British Journal of Anaesthesia 
Paul C. Adams, James C. Barton  Journal of Hepatology 
Immunosuppression in liver transplant recipients with renal impairment
Volume 57, Issue 3, Pages (September 2012)
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Volume 64, Issue 1, Pages (January 2016)
Epigenetic modifications as new targets for liver disease therapies
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Donor-recipient matching: Myths and realities
Chimeric mouse model of hepatitis B virus infection
The origin of biliary strictures after liver transplantation: Is it the amount of epithelial injury or insufficient regeneration that counts?  Negin Karimian,
Volume 61, Issue 3, Pages (September 2014)
Comment on the article “Age and liver transplantation”
Hepatitis E virus: Infection beyond the liver?
Volume 143, Issue 5, Pages (November 2012)
Volume 70, Issue 5, Pages (May 2019)
Robert J. Porte, MD, PhD Professor of Surgery
Presentation transcript:

Volume 61, Issue 3, Pages 672-684 (September 2014) Biomarkers to assess graft quality during conventional and machine preservation in liver transplantation  Cornelia J. Verhoeven, Waqar R.R. Farid, Jeroen de Jonge, Herold J. Metselaar, Geert Kazemier, Luc J.W. van der Laan  Journal of Hepatology  Volume 61, Issue 3, Pages 672-684 (September 2014) DOI: 10.1016/j.jhep.2014.04.031 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Incidence of ischemia/preservation related complications after LT. Estimation of the incidence of PNF, EAD, and ITBL in separate DBD and DCD grafts, based on cohort- and case-matched studies [5,9–11,76,86,110]. Percentages represent the mean incidence±standard error. Studies used to calculate the incidence of EAD maintained the criteria formulated by Olthoff et al. [9,10]. Definitions on PNF and ITBL can be found in the Supplementary data. Journal of Hepatology 2014 61, 672-684DOI: (10.1016/j.jhep.2014.04.031) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Risk factors for outcome following LT. Risk factors in donors, recipients and during the transplantation and transportation procedure influencing graft quality and graft/recipient outcome. Journal of Hepatology 2014 61, 672-684DOI: (10.1016/j.jhep.2014.04.031) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Mechanisms of various machine preservation strategies. Different techniques of graft preservation can be used to protect against ischemic injury, to recondition the graft before reperfusion or even to maintain physiology. The various techniques have different potentially protective underlying mechanisms. Via all techniques, graft quality could be evaluated through markers in tissue biopsies or perfusate analysis. The (sub)normothermic conditions also allow for the analysis and evaluation of bile. SCS, static cold storage; HMP, hypothermic machine perfusion; HOPE, hypothermic oxygenated machine perfusion; SNP, subnormothermic perfusion; COR, controlled oxygenated rewarming; NMP, normothermic machine perfusion. Journal of Hepatology 2014 61, 672-684DOI: (10.1016/j.jhep.2014.04.031) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Cumulative graft injury and evaluation points for graft quality. Already in an early phase of LT, known risk factors in donors and recipients could be used for deciding to accept a graft for transplantation and for which recipient. In order to determine the degree of preservation injury, biomarkers could be measured in tissue, perfusates or bile during various preservation methods. The cumulative injury of grafts that are preserved by hypothermic MP (either oxygenated or non-oxygenated) is believed to be less compared to static cold stored grafts (SCS). Mimicking normal physiological functions through (sub)normothermic MP is hypothesized to even recover injury of ECD grafts, for instance steatosis, and to provide a better assessment of graft function. After graft reperfusion, other functional tests are possible in order to monitor graft quality during follow-up. Journal of Hepatology 2014 61, 672-684DOI: (10.1016/j.jhep.2014.04.031) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 61, 672-684DOI: (10. 1016/j. jhep. 2014. 04 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions